Cite

    Benjamin M Ellingson et al.. “Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.” Neuro-oncology, vol. 20, no. 11, 2018, pp. 1525–1535. http://access.bl.uk/ark:/81055/vdc_100095323943.0x00001b